Nasdaq:US$18.99 (+0.58) | HKEX:HK$30.35 (+1.05) | AIM:£3.04 (+0.08)
搜索結果
上一篇文章   |   下一篇文章
公告及新聞稿, 腫瘤學 / 免疫學 | 2007-06-18

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility